• SENSEX 80,599.91
    -585.67 (--0.72%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zota Health Care Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 69688.0
  • ISIN : INE358U01012
1,212.10 -2 (-0.17%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    1,204.00

  • Today’s High

    1,276.90

  • Open

    1,223.90

  • Perv Close

    1,214.15

  • 52W Low

    535.00

  • 52W High

    1,305.00

Key Indicators

  • P/E(TTM)

    419.41

  • Mar.Cap (₹Cr.)

    3,608.01

  • Div & Yield %

    0.08

  • Book Value(₹)

    136.41

  • Debt-Equity Ratio

    -0.17

  • AGM Date

    01-Aug-2025

  • EPS

    2.89

  • P/E Ratio

    419.41

Financials Ratios

  • Debt-Equity Ratio

    0.82

  • Mar.Cap (₹Cr.)

    3,608.01

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    29.77

  • BV (₹)

    136.40

  • Sales( ₹ in Cr.)

    257.28

  • NP (in Cr.)

    8.62

  • NP Var(%)

    155.0

  • Div%

    10.0

  • CPS (₹)

    4.00

  • EPS (₹)

    2.90

  • Traded Value (₹ in Lakhs)

    3,608.01

  • 52 Week High

    1,305.00

  • 52 Week Low

    535.00

  • Price BSE

    0.0

  • Price NSE

    1,212.00

  • Market Capital( in Cr.)

    3,608.01

  • P/C Ratio

    306.00

  • P/E Ratio

    418.70

  • Price Vs.BV

    2.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 166.59 138.37 131.53 106.84 95.11 85.63
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.07
Net Sales 166.59 138.37 131.53 106.84 95.11 85.56
Other Income 2.05 3.10 1.65 2.29 1.51 1.54
Stock Adjustments 3.53 11.00 -1.48 2.14 -7.09 7.26
Total Income 172.17 152.47 131.70 111.27 89.53 94.36
EXPENDITURE :            
Raw Materials 108.83 99.41 86.67 75.88 59.57 64.62
Power and Fuel Cost 0.97 0.73 0.84 0.70 0.60 0.54
Employee Cost 18.85 10.73 9.15 8.58 9.59 8.02
Other Manufacturing Expenses 2.00 0.93 1.43 1.55 1.58 1.64
Selling and Administration Expenses 33.11 29.40 16.54 21.43 11.78 9.84
Miscellaneous Expenses 0.12 0.16 0.07 0.16 0.37 0.41
Employee Benefit Expenses 18.85 10.73 9.15 8.58 9.59 8.02
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 163.89 141.35 114.70 108.30 83.49 85.08
Operating Profit 8.27 11.10 16.99 2.96 6.05 9.29
Interest 0.36 0.06 0.07 0.11 0.07 0.04
Gross Profit 7.91 11.04 16.92 2.85 5.98 9.25
Depreciation 3.01 2.42 2.73 3.17 2.10 1.39
Profit Before Tax 4.90 8.62 14.19 -0.32 3.88 7.86
Current Tax 1.47 2.05 3.69 0.02 1.06 2.35
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.06 -0.02 -0.08 -0.17 0.06 -0.04
Reported Net Profit 3.38 6.59 10.58 -0.16 2.76 5.55
Extraordinary Items 0.00 0.40 0.00 0.94 0.00 0.00
Adjusted Net Profit 3.38 6.19 10.58 -1.10 2.76 5.55
Adjustment below Net Profit 5.70 0.27 0.14 0.14 -0.38 -1.14
P & L Balance brought forward 23.55 20.46 12.26 14.74 14.82 15.66
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2.58 3.77 2.52 2.46 2.46 5.26
P & L Balance carried down 30.05 23.55 20.46 12.26 14.74 14.82
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 15.00 10.00 10.00 10.00
Dividend Per Share(Rs) 1.00 1.00 1.50 1.00 1.00 1.00
Earnings Per Share-Unit Curr 1.31 2.62 4.21 -0.07 1.12 3.16
Earnings Per Share(Adj)-Unit Curr 1.31 2.62 4.21 -0.07 1.12 2.26
Book Value 47.11 37.54 36.32 27.02 28.03 39.29
Book Value(Adj)-Unit Curr 47.11 37.54 36.32 27.02 28.03 28.06

Shareholding Pattern

  • Promoter Group

    57.42%

  • Public Share Holding

    42.58%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 17,091,178 57.42 17,091,178 39
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 17,091,178 57.42 17,091,178 39
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,136,260 3.82 1,136,260 10
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,263,813 4.25 1,263,813 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,400,073 8.06 2,400,073 14
2] Non Institution
Bodies Corporate 1,030,894 3.46 1,030,894 85
Clearing Members 0 0.00 0 0
Directors of their Relatives 169,960 0.57 169,960 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 83,745 0.28 83,745 122
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 541,749 1.82 541,749 436
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,232,867 10.86 3,232,867 39
Individuals holding nominal share capital up to Rs. 1 lakh 3,939,523 13.23 3,913,165 9,545
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 81,096 0.27 81,096 3
Sub Total 10,275,331 34.52 10,248,671 10,301
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 29,766,582 100.00 29,739,922 10,354

Company Background

Zota Health Care LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Zota Health Care Ltd
  • BSE Code : 69688.0
  • ISIN : INE358U01012

  • Incorporation Year

    2000

  • Registered Office

    Zota House 2/896 Hira Modi St
    Sagrampura, Surat,
    Gujarat-395002

  • Telephone

    91-261-2331601

  • FAX

    91-261-2346415

  • Chairman

    Ketankumar Zota

  • Managing Director

    Moxesh Zota

  • Company Secretary

    Ashvin Variya

  • Auditor

    Shivangi Parekh & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Satellite Corporate Ser. P Ltd
    Unit-49 Bldg-13 AB ,
    Off Andheri Kurla Rd,MTNL Lane Sakinaka
    Mumbai - Mumbai-400072

Zota Health Care Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zota Health Care 1,212.10 168.64 166.59 419.41 4.52
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10